Gene · 384
Papers1,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE). | Front Physiol | 2023 | 38093907 | PubTator, text mining | PubMed |
| Targeting the myeloid microenvironment in neuroblastoma. | J Exp Clin Cancer Res | 2023 | 38087370 | PubTator, text mining | PubMed |
| Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury. | Front Cell Dev Biol | 2023 | 38054182 | PubTator, text mining | PubMed |
| The association of exhaled nitric oxide with air pollutants in young infants of asthmatic mothers. | Environ Health | 2023 | 38049853 | PubTator, text mining | PubMed |
| Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers. | Front Immunol | 2023 | 38022574 | PubTator, text mining | PubMed |
| HantaNet: A New MicrobeTrace Application for Hantavirus Classification, Genomic Surveillance, Epidemiology and Outbreak Investigations. | Viruses | 2023 | 38005885 | PubTator, text mining | PubMed |
| Inflammatory and Metabolic Signaling Interfaces of the Hypertrophic and Senescent Chondrocyte Phenotypes Associated with Osteoarthritis. | Int J Mol Sci | 2023 | 38003658 | PubTator, text mining | PubMed |
| The Multifaceted Role of Osteopontin in Prostate Pathologies. | Biomedicines | 2023 | 38001899 | PubTator, text mining | PubMed |
| Molecular and Metabolic Phenotyping of Hepatocellular Carcinoma for Biomarker Discovery: A Meta-Analysis. | Metabolites | 2023 | 37999208 | PubTator, text mining | PubMed |
| Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC). | J Transl Med | 2023 | 37968714 | PubTator, text mining | PubMed |
| TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification. | Aging (Albany NY) | 2023 | 37950731 | PubTator, text mining | PubMed |
| Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity. | J Exp Clin Cancer Res | 2023 | 37924140 | PubTator, text mining | PubMed |
| GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer. | Cancer Cell Int | 2023 | 37904122 | PubTator, text mining | PubMed |
| Exploring Gel-Point Identification in Epoxy Resin Using Rheology and Unsupervised Learning. | Gels | 2023 | 37888401 | PubTator, text mining | PubMed |
| Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target. | Signal Transduct Target Ther | 2023 | 37884518 | PubTator, text mining | PubMed |
| Role of The circ-HIPK3, circ-PVT1, miR-25, and miR-149 in Response of Breast Cancer Cells to Ionizing Radiation. | Cell J | 2023 | 37865877 | PubTator, text mining | PubMed |
| Arginase is upregulated in healthy women infected by oncogenic HPV types. | Biomarkers | 2023 | 37860844 | PubTator, text mining | PubMed |
| LncRNA MALAT1/microRNA-30b axis regulates macrophage polarization and function. | Front Immunol | 2023 | 37860007 | PubTator, text mining | PubMed |
| OSPAR: A Corpus for Extraction of Organic Synthesis Procedures with Argument Roles. | J Chem Inf Model | 2023 | 37859303 | PubTator, text mining | PubMed |
| Arginase2 mediates contrast-induced acute kidney injury via facilitating nitrosative stress in tubular cells. | Redox Biol | 2023 | 37856999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/384/papers?page=8